Skip to main content

Lumbar Spinal Fusion

1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Medical Metrics
Medical MetricsTX - Houston
1 program
1
Ketorolac TromethaminePhase 41 trial
Active Trials
NCT06513208Recruiting140Est. Jun 2027

Trial Timeline

Clinical trial activity over time

2026
2027
Medical MetricsKetorolac Tromethamine

Clinical Trials (1)

Total enrollment: 140 patients across 1 trials

NCT06513208Medical MetricsKetorolac Tromethamine

Ketorolac Effects on Post-operative Pain and Lumbar Fusion

Start: Jan 2026Est. completion: Jun 2027140 patients
Phase 4Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 140 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.